The company’s SpaceOAR System is designed to temporarily separate organs during radiotherapy so that normal tissues are spared, and to mark tumor resection sites to allow for targeted therapy.
Author: Global Cancer Consortium
Access Pharmaceuticals (OTC: ACCP.OB, “Access”) develops and commercializes products for the treatment and supportive care of cancer patients.
According to the American Heart Association, heart disease is the number one killer of women over age 25–more than the next five causes of death, or all forms of cancer, combined.
Ovatech of Auburndale, Mass., is developing the world’s first non-hormonal, female-controlled contraception device.
The idea of using harmful bacteria to treat disease might strike many as an odd concept.
All told, the Los Angeles-based company could have six to eight trials running simultaneously in the coming months.
Quintessence Biosciences is a biopharmaceutical company specializing in the development of novel protein-based therapeutics to fight cancer.
Inovio is developing a universal flu vaccine engineered to prevent several strains of influenza at once.